momentum medicar advantag continu
page full analyst note
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim jul
price data dec
rate updat dec
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
core compet plan sponsor medicar
advantag program support consist excess econom
return last decad follow consolid
industri complet fund cut center medicar
medicaid servic on-going support expans
medicar advantag program think dug narrow
econom moat competit nich local scale
relev market expand provid presenc regulatori
expertis put firm superior competit foot rel
mani smaller player offer market earli
establish leadership posit medicar advantag
program account bulk membership growth
across manag care industri think foresight
continu benefit sharehold especi polici discuss
around expand medicar program gain traction
commend manag maintain moat
firm sale aetna regulatori review continu
forg ahead deal fail gain approv strategi
defin multitud partnership joint ventur
differ area improv firm abil manag cost
care larg senior membership base wholli own
partner primari care clinic earli partnership
walgreen minor stake lead home health
hospic busi nation given manag flexibl
avenu tri lower cost care medicar advantag
nation dialogu around healthcar reform like intensifi
lead elect cycl contend
retain uniqu posit premier govern contractor
medicar advantag militari tricar system
think likelihood widespread industri disrupt rel
low posit potenti benefit
margin regulatori chang expans medicar elig
like benefit advantag program continu
expans medicaid like interest manag
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
one largest privat insur organ particip
medicar advantag program firm built nich special
government-sponsor program nearli medic membership
stem individu group medicar advantag medicaid
militari tricar program addit firm leader
stand-alon prescript drug plan offer senior enrol tradit
fee-for-servic medicar also nascent commerci offer
focus risk arrang alongsid specialti offer dental
vision life smaller employ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
momentum medicar advantag continu
share fairli valu
result beat consensu capit iq rais
guidanc share remain fairli valu
opinion quarter advantag
medicar advantag plan display continu
support moat growth opportun opinion
extrem potenti polici chang medicar
elimin privat insur industri
continu make headlin broader support exist
option would expand government-rel program
like medicar advantag could actual increas
opportun insur like intermedi
quarter revenu grew billion slightli
consensu adjust earn per share grew
consensu
particularli impress firm medicar advantag
membership momentum caus firm boost
membership growth expect member
previou expect rang
member moat perspect
quarter result highlight firm core compet
medicar advantag allow firm prosper
despit smaller medic membership roll
guidanc front compani rais earn per
share outlook provid cautiou outlook
compani rais adjust earn
per share guidanc previous
compani expect revenu growth doubl
digit earn growth long-term target
relat expect reinstat
health insur fee margin pressur associ
strong new member growth typic break-even margin
howev manag state consensu
impli mid-single-digit ep growth new
outlook like within project rang
fair valu estim per share impli roughli
time updat estim adjust
earn ebitda respect
valuat underpin assumpt
increas medic insur enrol
roughli annual come five year
help combin above-market growth
medicar advantag enrol estim
per year modest declin firm commerci group
specialti book busi assum premium
increas rate consist mid-single-digit cost
trend assumpt medic loss ratio remain
rel consist five-year forecast horizon
final assum overal oper cost see margin
limit improv percentag total revenu
normal volatil associ health
assumpt result consolid revenu growth
averag near annual come year
addit model impli adjust ebitda margin
see modest eros come year remain line
compani histor averag approxim
growth rate combin healthi alloc share
repurchas drive ep growth toward annual rate
concentr exposur government-sponsor
insur plan combin ever-pres risk
associ polici uncertainti manag care
warrant high uncertainti rate compani
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fair valu estim roughli time lower
forecast earn ebitda respect
believ develop narrow econom moat
stem cost advantag network effect
believ inher manag care organ
achiev local scale necessari gener
excess return capit firm medic
membership roll smaller integr peer
develop core compet medicar
consolid presenc hand state
allow compani prosper strategi creat
competit advantag busi within
medicar advantag market peer found difficult
replic
typic shi away award moat
healthcar servic provid entiti reli heavili
medicar program fund reimburs
medicar advantag histori privat market solut
make dynam market somewhat differ
rather unilater dictat price medicar
provid arena medicar advantag fund
provid privat plan basi annual bid
benchmark averag roughli annual cost
fee-for-servic program benchmark set statut
stratifi cost quartil counti level
beyond highest quartil counti project per
capita fee-for-servic spend benchmark
lower rate lowest cost area
benchmark rais give plan
flexibl price structur allow better
competit offer creat incent
compani lower cost high-util patient
ultim believ manag care busi
experi oper within regulatori framework
manag care specif need medicar
bull-cas scenario assum overal medic
enrol grow roughli annual help better
medicar advantag growth stabl commerci
offer assum premium growth line
mid-single-digit cost trend assumpt give compani
credit
control overal
oper expens consolid basi impli
compound annual revenu growth rate
termin oper margin beat
base-cas expect roughli basi point
assumpt result fair valu estim roughli
time higher estim adjust
earn ebitda respect
bear-cas outlook assum medic enrol
growth lag broader industri averag less
annual mid-single-digit cost trend
assumpt lead roughli revenu growth annual
averag margin declin across firm busi
segment assum firm termin ebitda margin
fall short base-cas expect roughli basi
point see earn growth fail surpass
mid-single-digit rate assumpt result
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
patient popul like succeed long
run clear leader front
nation level medicar advantag rel
consolid top insur account nearli
cover popul account
roughli total howev vast major
enrol local plan nation comparison doesnt tell
whole stori compani typic
number-on -two insur counti
offer plan compet heavili state
state firm overal enrol share fall closer
averag import develop
leverag rate paid local provid also
creat effici manag higher-cost popul
specif texa florida work
develop wholli own partner provid organ
creat seamless relationship among
patient clinic
within structur believ two relev moat sourc
emerg cost advantag network effect advantag
thought two way relat size
insur book busi first larger membership
base allow greater central fixed-cost leverag
increas profit potenti margin member
overal enterpris second larger membership base
allow greater negoti leverag versu provid
insur need creat plan network allow
lower medic cost per member opportun
lower premium improv benefit offer secur
focus build local scale shift balanc
power relationship given much higher
level concentr found industri larg
think scale frequent tip insur favor
particularli given plan abil leverag
network effect also play intertwin role patient
payer provid incumb plan enrol
grow relationship among three entiti becom
valuabl time patient plan
rel afford plan invest broader
swath benefit member payer expand
enrol allow greater per-memb profit
attract offer either better price
entic benefit packag provid
particip expand plan network provid access
greater patient volum key compon profit
busi high fix cost short run
dynam creat barrier entri would-b competitor
put togeth attract price provid network
new geographi prohibit difficult without
membership pool vice versa
think incumb benefit star-rat
system provid addit econom patient
awar plan score highli measur
outcom process patient experi access plan
market longer shown
typic score higher averag star-rat score
like attribut contract consolid effort
better rate manag experienc plan
star system act market tool success
plan along provid increment payment allow
effect oper offer comprehens
benefit packag potenti member help spur
enrol growth membership
contract rate star higher compar
industrywid averag nearer plan year
final think ownership fourth-largest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
industri level may face futur cyclic challeng
associ weaken economi rise uninsur
rate medicar advantag uniqu insul
macro shift due natur membership base
pharmaci benefit manag grow presenc
provid space help support strong outcom cost
manag need run success plan
direct ownership partnership arrang
firm forefront build
comprehens value-bas offer help firm
better manag overal cost burden shift
financi risk provid notabl manag
claim membership current
manag full-risk arrang provid
shown produc lower medic loss ratio
think underli sourc underpin econom
moat manag care larg stabl assign
stabl moat trend rate compani post
attract return capit last five year
character on-going chang healthcar
industri importantli firm growth larg
organ littl goodwil balanc sheet depress
report return view scenario firm
underli cost advantag network effect materi
erod substanti strengthen unlik durat
five-year forecast period howev
implement fund medicar advantag
propos chang
demograph suggest secular enrol growth
like come lower-margin medicar cohort
forese futur view result mix
effect sever enough suggest firm
underli competit advantag weaken
addit commerci increasingli small portion
profit firm doubt neg mix
effect would notic consolid financi
posit compani similarli futur enrol
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
leadership posit fast-grow
medicar advantag market posit firm
captur above-market enrol growth time
owhil window horizont merger opportun
manag care appear close think
asset particip industri
provid asset
acceler stake kindr
add compet care
concentr exposur feder state
program fund sourc revenu creat
acut risk busi feder deficit continu
expand
ohealthcar reform like recur topic
throughout elect cycl could creat
increas stock volatil pose real fundament
threat public-opt propos gain traction
opolici propos look curb chang use
rebat throughout system could creat disrupt
throughout suppli chain hinder pbm efficaci
profit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
balanc sheet solid shape compani
gross debt balanc equat roughli time adjust
ebitda modestli higher histor leverag level
manag view compani maintain
debt/capit ratio roughli slightli higher
manag long-term target addit
compani tend keep roughli million cash hand
parent give busi ampl liquid
manag focus consist dividend rais
opportunist share buyback return excess capit
concentr exposur government-sponsor
insur plan combin ever-pres risk
associ polici uncertainti manag care
warrant high uncertainti rate compani
nearli firm nonmilitari membership tie
way govern fund medicar advantag
stand-alon drug plan medicaid chang
feder state budget prioriti pose acut risk
firm aca-mand fund cut medicar
advantag program complet limit
impact firm remain uniqu expos
unilater chang diversifi peer like
better posit handl hand
rhetor around healthcar reform like intensifi
elect season think passag
implement sweep chang remot
possibl think chang margin like
modif afford act continu
expans medicaid creat earli buy-in option
medicar wouldnt surpris see privat
insur play role improv coverag
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
give humana standard mark stewardship bruce
broussard overseen substanti valu creation sinc
elev ceo think firm abil report
consist strong result backdrop chang
healthcar polici landscap impress credit
manag polici thought opportunist capit
firm board put togeth well-structur incent
scheme align manag interest
sharehold view annual bonu payment
measur adjust earn per share net promot
score strateg measur firm long-term
incent program mix option restrict stock
measur
three-year cumul return invest capit target
along stock perform benchmark peer
think combin provid balanc
growth profit reinvest need ensur
manag decis align long-term goal
sharehold
final major consider stewardship
methodolog pleas compani polici
separ board chairman ceo posit
repres date owner name posit common share held report holder issuer
american fund growth fund amer
fidel manag research compani
america corp
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
outlook manag includ risk
valuat attract across board aug
took detail look managed-car industri
came away confid posit outlook space
manag care remain attract industri
allow format sizabl econom moat
protect strong return capit almost everi corner
sector compani built advantag busi
model around monthli premium fee gener
recur revenu consolid past decad
allow competit remain ration despit
attract qualiti group trade modest discount
broader market reflect investor concern
futur healthcar polici regul unit
headlin domin variou democrat
parti polici propos medicar
would overhaul healthcar industri addit
manag care wrestl propos regulatori action
put forward trump administr so-
call rebat rule think medicar
function similar polici unlik next decad
administr abandon rebat rule earlier
year mark win industri valuat space
compress result heighten concern
market particip regard action think
investor long-term invest horizon stand
benefit own moatworthi firm favor
price integr servic offer unitedhealth
group make favorit among
five firm cover current trade discount
dcf-deriv fair valu estim
uncertainti like persist
gener elect cycl think group averag
valuat level roughli time earn emb
sizable-enough margin safeti warrant posit
detail analysi industri
assess potenti polici implic pleas see
risk manag creat opportun
moatworthi firm sizabl discount
favor trend continu share
post solid second-quart result came
well ahead consensu expect larg
back better medic cost manag rais
fair valu estim narrow-moat firm per
share account out-performance
cash flow receiv sinc last updat still
consid share fairli valu roughli time
like first quarter enrol trend continu outpac
expect particularli firm individu medicar
advantag busi membership addit quarter
put segment pace expand midteen rate well
ahead market growth like nearer mid- high-singl
digit addit favor util trend segment
continu throughout second quarter retail
segment medic loss ratio came nearli
basi point lower model drive profit upsid
enterpris manag full-year guidanc
metric came roughli basi point result
still look rel conserv given typic second-
half declin seen year past
off-set commerci segment came
substanti wors forecast wipe much
segment profit howev rel size
book busi compar government-
sponsor organ limit overal import
enterpris million lower profit expect
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
altern expect senat drug price packag
could includ part reform also includ cap
out-of-pocket spend medicar part anticip
propos would see widespread support
policymak result higher likelihood
success think chang would manag
drug firm effect achiev bipartisan
polici goal lower healthcar cost american
addit detail analysi effect
rebat rule elimin pleas see report rebat
segment larg driven varianc suggest
book return normal expens level
second half year
final manag signal confid busi
announc billion acceler share repurchas
program account roughli firm market
cap current valuat
first report juli axio trump administr
plan final propos rule alter flow
drug rebat purchas medicar part plan
rule would chang busi model
pharmaci benefit manag requir negoti
discount pass directli beneficiari
point sale rather use mechan lower
cost insur plan overal led ralli
pbms/insur distributor drug stock sank
investor wonder presid donald trump focu
turn next take rebat reform tabl put
pressur congress particularli bipartisan senat
financ committe team chuck grassley ron wyden
reveal drug-pric packag month stand
chanc pass chamber potenti reform
like reduc cost medicar patient also look
modest payer drug firm
think remain propos review
budget offic -- medicar part intern price
index -- unlik implement even final
congress power block rule judici review
could find massiv demonstr overextens
author center medicar medicaid
innov cmmi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
